Tamoxifen and Breast Cancer Incidence Among Women With Inherited Mutations in BRCA1 and BRCA2
Data up to Jan 2025
Total Citations Per Year
Abstract
References (36)
Base-Calling of Automated Sequencer Traces UsingPhred. I. Accuracy Assessment
1998 • 6,925 citations
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
1994 • 5,994 citations
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 • 5,487 citations
Base-Calling of Automated Sequencer Traces Using Phred. II. Error Probabilities
1998 • 5,382 citations
Tamoxifen for early breast cancer: an overview of the randomised trials
1998 • 4,082 citations
Identification of the breast cancer susceptibility gene BRCA2
1995 • 3,581 citations
Consed: A Graphical Tool for Sequence Finishing
1998 • 3,325 citations
Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually
1989 • 3,239 citations
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
1990 • 2,505 citations
Cancer Risks in BRCA2 Mutation Carriers
1999 • 1,477 citations
A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
1989 • 1,471 citations
PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing
1997 • 946 citations
Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutation
2001 • 945 citations
Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer
1999 • 866 citations
Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer
1999 • 676 citations
Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers
1999 • 674 citations
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
2001 • 626 citations
Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases
1997 • 580 citations
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
2000 • 536 citations
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1
1998 • 453 citations
Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer
1999 • 390 citations
Frequency of Breast Cancer Attributable to <EMPH TYPE="ITAL">BRCA1</EMPH> in a Population-Based Series of American Women
1998 • 350 citations
Tumour biological features of BRCA1-induced breast and ovarian cancer
1997 • 346 citations
BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer
2000 • 311 citations
BRCA-associated breast cancer in young women.
1998 • 309 citations
Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1.
1996 • 272 citations
Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
1999 • 229 citations
Frequency ofBRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases
2000 • 207 citations
Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes
1998 • 185 citations
Survival in Hereditary Breast Cancer Associated With Germline Mutations of BRCA2
1999 • 183 citations
Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women
1997 • 177 citations
BRCA1-related breast cancer in Austrian breast and ovarian cancer families: SpecificBRCA1 mutations and pathological characteristics
1998 • 98 citations
Breast Carcinomas Arising in Carriers of Mutations in BRCA1 or BRCA2: Are They Prognostically Different?
1999 • 95 citations
BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations
1999 • 31 citations
SeqHelp: A Program to Analyze Molecular Sequences Utilizing Common Computational Resources
1998 • 28 citations
Incidence of BRCA1/2 germ line alterations in a high risk cohort participating in a phase II chemoprevention trial
2000 • 6 citations
Cited By (0)
No citing papers found in database